clinic_doc

15

Jul2020
Checkout this article published in the American Diabetes Association’s Diabetes Care issue regarding the comparison of “Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes”. It’s an honor to share the involvement of Dr. Frias and NRI in this important study!   ... Read More
July 15, 2020clinic_doc
clinical-trials-day1

20

May2020
Clinical Trials Day is a special day to recognize the people who conduct clinical trials and thank them for improving public health. This day is also an opportunity to raise awareness about clinical trials. We'd like to thank and celebrate all clinical research professionals, including our very own at NRI, for ... Read More
May 20, 2020clinic_doc

11

May2020
We are excited to share some great work from Dr. Frias and the NRI team regarding Dulaglutide’s significant results tied to A1C and weight reduction in diabetes. We are so proud of the valuable results from of our involvement with this Eli Lilly study. https://medicaldialogues.in/diabetes-endocrinology/news/higher-doses-of-dulaglutide-reduces-blood-sugar-and-weight-in-diabetes-65621
May 11, 2020clinic_doc

07

May2020
Results showed a statistical significant reduction in liver fat in patients with NASH and diabetes. Our contribution to this important study is what makes us proud of what we do! https://www.businesswire.com/news/home/20200507005019/en/HighTide-Therapeutics-Announces-Positive-Topline-Results-Phase
May 7, 2020clinic_doc

06

May2020
Axcella announces top-line data from AXA1125-003 clinical study on adult subjects with NAFLD. Exciting news to share as contributors to this study! https://ir.axcellahealth.com/news-releases/news-release-details/axcella-announces-positive-top-line-data-axa1125-003-clinical
May 6, 2020clinic_doc
Minie-Mercado2

28

Apr2020
She has conducted studies from Phase 1-4 for the past 25 years. Some of her experience expands CNS, Metabolic and Liver Disease. Prior to NRI, she was head of NASH research with a local Hepatology center. We are very excited to have her join our NRI team and help us ... Read More
April 28, 2020clinic_doc

23

Apr2020
Post hoc analyses reveal promising results from the LixiLan‐G trial involving adults with type 2 diabetes. Kudos to Dr. Frias, our NRI team, and everyone involved! https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14068
April 23, 2020clinic_doc

12

Feb2020
February 12, 2020clinic_doc
metacrine

22

Jan2020
January 22, 2020clinic_doc
dr-frias-suit

02

Jan2020
January 2, 2020clinic_doc
Our Response to COVID-19
X